This theory was supported by the observations from Munn's group which indicate that overexpression of IDO in antigen-presenting cells (APCs) was the major cause of tumor-derived immune tolerance in local lymph nodes of patients with breast cancer or melanoma [39]. This evidence concerns the gene IDO1 and breast cancer.